Engineered to satisfy stringent EU MDR standards, our bone graft substitutes and prosthetic systems support orthopaedic trauma centers, dental reconstructive surgeons, and veterinary clinics across the Grand Duchy of Luxembourg.
Biphasic HA/β-TCP porous granules & sintered blocks. Highly osteoconductive bone void filler for orthopedic & dental regeneration.
Advanced microprocessor-controlled orthotic knee joint featuring multi-axis stance dynamic stability for adult rehabilitation.
Precision-machined joint prosthesis system engineered for severe osteoarthritis treatment and joint reconstruction surgery.
Medical-grade Cobalt-Chromium-Molybdenum (CoCrMo) alloy investment castings tailored for long-term biocompatibility and low wear rates.
Arthroscopic knee surgical instrument set with needle pre-loaded implants for rapid, secure inner meniscal repair.
Comprehensive orthopedic surgical instrument array designed for accurate tibial resection and total hip/knee implant positioning.
Ergonomic operative leg positioner brace providing solid limb immobilization during total joint arthroplasty procedures.
CE-marked stainless steel/titanium veterinary orthopedic instrument set engineered for canine & feline patellar groove replacement.
In modern orthopaedic surgery, spinal fusion, and reconstructive dental procedures, bone grafting materials are indispensable for repairing segmental defects, treating non-union fractures, and providing a stable scaffold for new tissue growth. Historically, autografts (harvested from the patient’s iliac crest) were regarded as the gold standard. However, donor site morbidity, limited harvest volume, prolonged operating times, and surgical risks have accelerated the adoption of synthetic bone graft substitutes across European healthcare networks, particularly within the Grand Duchy of Luxembourg.
As a leading international manufacturer and exporter supplying surgical procurement teams in Luxembourg City, Esch-sur-Alzette, and Ettelbruck, Bharucha Associates produces synthetic Hydroxyapatite (HA) bone graft substitutes tailored to strict biomechanical and biological criteria. Synthetic HA provides an inert, biocompatible, and structurally predictable lattice. Through precise thermal sintering processes, our engineered hydroxyapatite matrices achieve controlled macro-porosity (100–500 µm) and micro-porosity (<10 µm), replicating the native trabecular bone architecture.
The biological efficacy of synthetic bone grafts hinges upon their porous framework. Isolated pores fail to facilitate full tissue vascularization. Bharucha Associates utilizes advanced space-holder and polyurethane replica techniques to synthesize interconnected pore channels within the HA graft matrix:
Enables osteoblast adhesion, cell proliferation, capillary sprouting (angiogenesis), and deep Haversian canal formation throughout the graft depth.
Increases specific surface area for protein adsorption (osteocalcin, osteopontin), accelerates body fluid penetration, and facilitates ion exchange.
Customizable ratios (e.g., 60% HA / 40% β-TCP) balance slow-resorbing structural support with rapid resorbable tricalcium phosphate dissolution.
Optimized compressive strength matching human cancellous bone (2–12 MPa), ensuring structural stability during operative compaction.
| Property Parameter | Pure Synthetic HA (100% HA) | Biphasic HA / β-TCP (60/40) | Clinical Significance for Surgeons |
|---|---|---|---|
| Chemical Composition | Ca10(PO4)6(OH)2 | 60% HA / 40% Ca3(PO4)2 | Exact stoichiometric match to natural hydroxyapatite phase |
| Ca/P Molar Ratio | 1.67 ± 0.02 | 1.58 ± 0.03 | Prevents cytotoxic phase impurities and unreacted lime |
| Total Porosity (%) | 70% – 85% | 65% – 80% | Optimized balance between void space and compressive load handling |
| Interconnected Pore Size | 150 – 450 µm | 100 – 500 µm | Directly supports vascular osteon formation & bone ingrowth |
| Compressive Strength | 4 – 10 MPa | 3 – 8 MPa | Resists surgical pressure during void packing in orthopaedic sites |
| Resorption Rate | Very Slow (Years) | Moderate (6–18 Months) | Provides permanent scaffold vs dynamic remodeling synchrony |
| Sterilization Method | Gamma Irradiation (25 kGy) | Gamma Irradiation (25 kGy) | Achieves Sterility Assurance Level (SAL) of 10-6 |
Luxembourg’s medical sector operates under exceptionally rigorous clinical oversight, led by premier hospital networks such as the Centre Hospitalier de Luxembourg (CHL), Hôpitaux Robert Schuman (Kirchberg Hospital & ZithaKlinik), and Centre Hospitalier Emile Mayrisch (CHEM). Medical practitioners, chief orthopaedic surgeons, and hospital procurement departments require biomaterials that combine safety, predictable resorption, and full compliance with European Union CE mark requirements.
In total hip (THA) and total knee (TKA) revision surgeries performed at major Luxembourg orthopaedic units, osteolysis often leaves severe cavitary defects. Synthetic HA granules are utilized as dense bone void fillers alongside investment-cast CoCrMo implants, providing immediate mechanical scaffolding and long-term biological bone substitution.
Spinal surgeries for degenerative disc disease or traumatic vertebral fractures in Luxembourg clinics increasingly favor synthetic bone graft porous blocks loaded with bone marrow aspirate (BMA). This combination eliminates the need for autologous crest harvesting, significantly shortening patient recovery times.
Private dental clinics and oral surgery units across Luxembourg City utilize micro-granule HA formulations (0.25mm – 1.0mm) for sinus lifts, socket preservation following extraction, and lateral ridge augmentation prior to titanium dental implant placement.
Luxembourg’s specialized veterinary referral hospitals frequently perform Patellar Groove Replacement (PGR) and TPLO procedures. Utilizing specialized PGR kits and synthetic HA blocks enables veterinary surgeons to restore joint biomechanics in canine patients effectively.
The Luxembourg healthcare market represents one of the highest per-capita healthcare expenditure regions globally. Hospital procurement policies enforced by the Direction de la Santé and backed by the Caisse Nationale de Santé (CNS) reimbursement frameworks prioritize patient safety, environmental sustainability, and verifiable clinical performance.
Founded in 1994 in Vadodara, India, Bharucha Associates has established itself as an authoritative global manufacturer, exporter, and supplier of medical equipment, orthopaedic surgical instruments, battery-operated drills, and biomaterials. Under the visionary leadership of Proprietor Mr. Devang Bharucha, the enterprise has expanded its supply footprint to over 40 countries, including key healthcare hubs throughout Europe.
Our production facility employs Class 10,000 cleanrooms for biomaterial synthesis, sintering, packaging, and gamma sterilization validation, guaranteeing batch-to-batch consistency.
By controlling the entire supply chain—from raw mineral precipitation to finished sterile packaging—we eliminate intermediary markups, offering Luxembourgish importers competitive pricing schedules.
Beyond hydroxyapatite bone grafts, we supply total surgical suites: power drills, oscillating saws, CoCrMo joint replacements, meniscal repair devices, and post-op intelligent orthoses.
Streamlined export documentation and direct freight corridors via Luxembourg Findel Airport (LUX) ensure rapid customs clearance and uninterrupted hospital supply chains.
Partner with Bharucha Associates for certified, high-gain synthetic bone graft materials, orthopaedic instruments, and prosthetic systems. Our international trade desk is ready to assist your procurement team.
Contact Us